Manhattan Scientifics, Inc. Issues Follow Up Report To Shareholders -"Pushing The Limits Of Cancer Detection"
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Three months ago Manhattan Scientifics (OTCQB: MHTX) announced the delivery of its 1st breakthrough cancer measurement instrument to M.D. Anderson Cancer Center in Houston.
The Company's technology uses iron oxide nanoparticles and a technique it calls Magnetic Relaxometry to locate and measure cancers with a sensitivity that would provide a diagnosis years before other known methods. It is generally believed that very early detection of cancers may well lead to their early elimination prior to metastasis and growth.
Help employers find you! Check out all the jobs and post your resume.
The Company's technology uses iron oxide nanoparticles and a technique it calls Magnetic Relaxometry to locate and measure cancers with a sensitivity that would provide a diagnosis years before other known methods. It is generally believed that very early detection of cancers may well lead to their early elimination prior to metastasis and growth.
Help employers find you! Check out all the jobs and post your resume.